Abstract
Tricyclic 6,7-dihydro-4H-pyrazolo[1,5-a]pyrrolo[3,4-d]pyrimidine-5,8-dione was identified as a novel scaffold for Aurora kinase A inhibition through virtual screening. SAR exploration coupled with molecular modeling of 8a reveals the minimum pharmacophore requirements for Aurora kinase A inhibition.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aurora Kinases
-
Binding Sites
-
Models, Molecular
-
Molecular Structure
-
Protein Serine-Threonine Kinases / antagonists & inhibitors*
-
Protein Serine-Threonine Kinases / chemistry
-
Pyrazoles / chemistry*
-
Pyrimidinones / chemistry*
-
Pyrroles / chemistry*
-
Structure-Activity Relationship
Substances
-
6,7-dihydro-4H-pyrazolo-(1,5-a)pyrrolo(3,4-d)pyrimidine-5,8-dione
-
Pyrazoles
-
Pyrimidinones
-
Pyrroles
-
Aurora Kinases
-
Protein Serine-Threonine Kinases